India Dealbook: GMS Holdings to invest $21.9m in Stelis Biopharma, GE’s open offer to acquire stake in Alstom fails

Stock market disclosures have brought to light two deal-related developments in India. The first being that GMS Holdings has invested in biotech firm Stelis Biopharma, a part of drug firm Strides Shasun, and the other involved US firm GE’s Rs 1,926 crore open offer to acquire stake in Alstom T&D failing to take off.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe